Viking Global Investors
LBPH

Viking Global Investors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Viking Global Investors’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,969,041
Closed -$65.6M – 105
2024
Q3 		$65.6M Buy
1,969,041
+310,079
+19% +$10.7M 0.24% 69
2024
Q2 		$44.8M Buy
1,658,962
+677,634
+69% +$13.4M 0.17% 71
2024
Q1 		$21.2M Buy
+981,328
New +$21.4M 0.08% 79

Viking Global Investors's LBPH Position: Q4 2024 in Review

Viking Global Investors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 1,969,041 shares — an estimated $65.6M sold.

Viking Global Investors first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $65.6M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Viking Global Investors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Viking Global Investors sold 1,969,041 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $65.6M.
  • Viking Global Investors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Viking Global Investors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $65.6M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Viking Global Investors's 13F filing for Q4 2024, filed 14 Feb 2025.